By Anna Wilde Mathews 

A judge blocked a federal rule that was expected to limit dialysis providers' ability to help patients pay for individual insurance plans.

U.S. District Judge Amos Mazzant, in Sherman, Texas, issued an order delaying the rule indefinitely while he hears a suit opposing it filed by major dialysis providers and a patient group. The plaintiffs, which included DaVita Inc. and Fresenius Medical Care North America, a subsidiary of a German company, argued that the Department of Health and Human Services had improperly rushed out the rule and that it could hurt patients.

A spokesman for the department declined to comment.

The Trump administration's long-term stance on the rule isn't yet clear. It will be closely watched by health insurers, which have objected to the payments that are the focus of the rule. In a statement, DaVita applauded the judge's order and said it wanted the new administration to eliminate the rule.

The judge had earlier blocked the rule for two weeks, and Wednesday he said he would fully grant the dialysis firms' request for a temporary restraining order. The judge's order said that the federal agency "did not have good cause to bypass" typical regulatory procedures when it issued the rule, and "thus, the rule should be vacated." Also, he wrote that the dialysis providers were likely to succeed in their case because the rule was "arbitrary and capricious."

The rule took aim at a setup that has come under fire from health insurers, particularly those offering plans on the Affordable Care Act's marketplaces. Under the setup, dialysis patients get help paying their health-insurance premiums from a charity, which itself gets funding from dialysis providers. Dialysis providers are typically paid more for their services when they treat patients with private insurance, compared with the reimbursement they get from government programs such as Medicare and Medicaid.

The rule would require dialysis providers to tell insurers when their patients are getting help from the providers, directly or indirectly, to pay premiums for individual insurance plans. The providers are also supposed to get assurances the insurer will accept those payments.

Analysts have said insurers would likely often refuse the payments, with the result that some patients wouldn't be able to enroll in the individual plans.

Write to Anna Wilde Mathews at anna.mathews@wsj.com

 

(END) Dow Jones Newswires

January 25, 2017 20:52 ET (01:52 GMT)

Copyright (c) 2017 Dow Jones & Company, Inc.
Fresenius Medical Care (NYSE:FMS)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Fresenius Medical Care Charts.
Fresenius Medical Care (NYSE:FMS)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Fresenius Medical Care Charts.